We report a patient with myasthenia gravis (MG) who had marked clinical benefit in response to treatment with mycophenolate mofetil as documented by serial quantitative measures of strength and muscle fatigue. Our patient had experienced either adverse side effects or a suboptimal response to the us
โฆ LIBER โฆ
Acquired pure megakaryocytic aplasia: Report of a single case treated with mycophenolate mofetil
โ Scribed by Deepti Bulchandani; Jagdish Nachnani; Robert Belt; Stuart Hinton
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- English
- Weight
- 90 KB
- Volume
- 82
- Category
- Article
- ISSN
- 0361-8609
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Treatment of myasthenia gravis with myco
โ
Matthew N. Meriggioli; Julie Rowin
๐
Article
๐
2000
๐
John Wiley and Sons
๐
English
โ 87 KB
๐ 2 views
Acquired pure megakaryocytic aplasia rep
โ
Leach, Joseph W.; Hussein, Khader K.; George, James N.
๐
Article
๐
1999
๐
John Wiley and Sons
๐
English
โ 34 KB
๐ 1 views
Acquired pure megakaryocytic aplasia is a rare disorder defined by severe thrombocytopenia with no other hematologic abnormalities and absent, or severely decreased marrow megakaryocytes. The etiology may be immune suppression of megakaryocyte development. Two patients are described who both respond